Trial
NCT00113919
UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Arkansas
Collaborators
—
Condition
Multiple Myeloma
Intervention
Busulfan
Why stopped
Due to poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-10-16